Literature DB >> 7786877

Placebo: a potent but misunderstood psychotrope.

Y D Lapierre.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7786877      PMCID: PMC1188681     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  10 in total

1.  Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.

Authors:  J H Greist; J W Jefferson; R Rosenfeld; L D Gutzmann; J S March; N E Barklage
Journal:  J Clin Psychiatry       Date:  1990-07       Impact factor: 4.384

2.  [Mesoridazine therapy in neurotics-clinical trial].

Authors:  Y D Lapierre; J Lavallée; L Tétreault
Journal:  Union Med Can       Date:  1972-08

3.  Discontinuation of neuroleptic medication in older, outpatient schizophrenics. A placebo-controlled, double-blind trial.

Authors:  P E Ruskin; G Nyman
Journal:  J Nerv Ment Dis       Date:  1991-04       Impact factor: 2.254

4.  Use of placebo controls in clinical trials disputed.

Authors:  G Taubes
Journal:  Science       Date:  1995-01-06       Impact factor: 47.728

5.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

6.  Increased motor activity and recurrent manic episodes: predictors of rapid relapse in remitted bipolar disorder patients after lithium discontinuation.

Authors:  E Klein; P Lavie; R Meiraz; A Sadeh; R H Lenox
Journal:  Biol Psychiatry       Date:  1992-02-01       Impact factor: 13.382

Review 7.  Methods of evaluation of psychoactive drugs.

Authors:  P Bech
Journal:  Recenti Prog Med       Date:  1989-12

8.  A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder.

Authors:  D W Black; R Wesner; W Bowers; J Gabel
Journal:  Arch Gen Psychiatry       Date:  1993-01

9.  A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.

Authors:  G Chouinard
Journal:  Acta Psychiatr Scand Suppl       Date:  1990

10.  Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.

Authors:  J W Stewart; P J McGrath; F M Quitkin; W Harrison; J Markowitz; S Wager; M R Leibowitz
Journal:  Arch Gen Psychiatry       Date:  1989-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.